Profilo
Florence Alouch is the founder and former Chief Executive Officer of SparingVision SAS, which was founded in 2016.
Currently, she is the Chairman-Supervisory Board at Génomic Vision SA since 2022.
Ms. Alouch holds an MBA from École des Hautes Études Commerciales de Paris and a graduate degree from Universite Paris Cite.
Posizioni attive di Florence Alouch
| Società | Posizione | Inizio |
|---|---|---|
| GENOMIC VISION | Presidente | 11/07/2022 |
Precedenti posizioni note di Florence Alouch
| Società | Posizione | Fine |
|---|---|---|
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Amministratore Delegato | - |
Formazione di Florence Alouch
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| Universite Paris Cite | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENOMIC VISION | Health Technology |
| Aziende private | 1 |
|---|---|
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Florence Alouch
